• RaySearch Laboratories
    Sveavägen 44 10365 Stockholm
    +46 8 510 530 00
    +46 8 545 061 39
  • Quotes

    In the third quarter of 2022, order intake increased by 71 percent and net sales rose 55 percent. Operating profit amounted to SEK 12 M (-27) in the third quarter and SEK 22 M (-37) for the first nine months.
    Johan Löf, CEO of RaySearch
    It is satisfying to note that the quarter had the highest order intake and net sales ever for a third quarter. It is regrettable that we are moving our reporting date, however I am confident and assured that we have taken the necessary steps to ensure future reporting.
    Johan Löf, founder and CEO, RaySearch
    “We look forward to collaborating with the McLaren Proton Center on both conventional proton therapy and exciting new treatment approaches.  RaySearch recently announced a partnership with Leo Cancer Care, and the implementation of RayStation in the McLaren center will enable the center to fully utilize this technology.
    Johan Löf, founder and CEO of RaySearch
    We are excited to being back on site at ASTRO to meet partners and existing and new customers to showcase the latest innovations with our products. Among other things, we are proud to highlight promising innovations within online adaptive together with our partner Accuray, as well as presenting our new partnerships with Leo Cancer Care and GE HealthCare.
    Johan Löf, founder and CEO, RaySearch
    Günther has a strong commitment to RaySearch and the fight against cancer. I believe he can become an excellent addition to RaySearch's Board.
    Johan Löf, founder and CEO, RaySearch
    IEO Milano is a world-renowned center with long experience from using RayStation. As they now are implementing proton therapy, I am happy that they have decided to expand the existing installation as well as adding RayCare as their oncology information system. RayStation is by far the market leading treatment planning system for proton therapy and this order confirms the interest we are now seeing in adding RayCare in order to get a seamless solution and the full RaySearch experience in a single software platform.
    Johan Löf, founder and CEO, RaySearch
    I would like to take the opportunity to thank Lars and Johanna for their work and commitment to RaySearch and wish them the best of luck in the future. I also look forward to working with Hans as Chairman. As a doctor, professor emeritus and former principal of KI, he covers a unique scope in medicine and medical technology. In addition, he has been part of RaySearch's Board since 2004 and knows the company very well.
    Johan Löf, founder and CEO, RaySearch
    Canada has one of the world’s most advanced cancer care programs. RaySearch has many strong relationships with Canadian centers, both clinical and academic, and we are proud to see that also Sunnybrook has put their trust in us and our innovative software. We look forward to working with this large and well-known center to further advance cancer treatment.
    Johan Löf, founder and CEO, RaySearch
    We have been following the work of Leo Cancer Care for quite some time, and we find that their approach to radiation therapy is a smart, effective, and potentially revolutionizing development. Like so many of the other contributions to the field that bear the signature of Rock Mackie, the idea of upright radiation treatment is well thought out and makes a lot of sense for a very wide range of indications. I am happy that we have now taken the step to formalize the relationship with Leo Cancer Care and I believe our technologies have great potential together.
    Johan Löf, founder and CEO, RaySearch
    In the second quarter of 2022, order intake increased by 12 percent and net sales rose 3.7 percent. Operating loss amounted to SEK -19.5 M (-22.5) in the second quarter and the operating profit for half-year amounted to SEK 10.0 M (-10.2).
    Johan Löf, CEO of RaySearch
    There are only a few Request For Proposals in the United States, and it is gratifying when we win these, which are based on objective measures. We look forward to a long and successful relationship with the University of New Mexico Comprehensive Cancer Center and to contributing to advanced technology in the care for the hospital’s patients.
    Johan Löf, founder and CEO, RaySearch
    I am very happy to be able to welcome Henrik to the position of CFO at RaySearch and to our management team. In addition to having a solid background and long experience as CFO of international and listed companies, he is also well versed in our industry. His experience of growing companies will also be valuable considering RaySearch’s expansive phase.
    Johan Löf, founder and CEO, RaySearch
    We are happy to welcome reputable Smith Clinic at Harris Health as our customer and look forward to a rewarding collaboration and the opportunity to contribute to improved care for the center’s patients.
    Johan Löf, founder and CEO, RaySearch
    Recently SNUH decided to invest in our treatment planning system RayStation. Now I am happy to state that this prominent hospital has decided to also buy RayCare for their carbon ion center. With the additional order from SNUH RaySearch confirms our market leading position in this unique segment as well as acknowledges the fact that the number of new customers who choose RayCare as their oncology information system is increasing.
    Johan Löf, founder and CEO, RaySearch
    Sweden is a pioneering country and a hub for research within radiotherapy technology. All research and development at RaySearch takes place in Sweden – 200 of our employees are working with this. For many years Norrlands universitetssjukhus and RaySearch have collaborated in various research projects and I am really happy that our technology now will be used clinically at another university hospital in our home country.
    Johan Löf, founder and CEO, RaySearch
    Making deep learning segmentation available to all users will substantially reduce time for contouring of organs and is a good example of our ambition to automate the treatment planning process.
    Johan Löf, founder and CEO, RaySearch
    Adaptive radiation therapy (ART) has been a focus area for RaySearch for more than 20 years, and it is rewarding to see that daily online ART for photon treatments finally is getting into clinical use. However, online ART may be even more important for proton therapy, which hopefully will be the next step for the community. To achieve this goal, it is pivotal that academic institutions, clinics, and vendors of treatment planning systems, oncology information systems, and proton delivery systems work closely together. With the ProtOnART consortium we have managed to assemble exactly these competences.
    Johan Löf, founder and CEO, RaySearch
    We are seeing a strong increase in interest in RayCare. This is driven by RayCare being the next generation oncology information system and by RaySearch's position as a vendor neutral oncology information system provider. It is clear that cancer clinics around the world see RayCare as an attractive route to more efficient, safer, and better integrated cancer care.
    Johan Löf, founder and CEO, RaySearch
    I am happy that we have signed our first agreement with Mevion China and look forward to our collaboration and to be able to contribute to further improving the treatment for cancer patients at Tongji Hospital.
    Johan Löf, founder and CEO, RaySearch
    Xavier Vermeren, chief medical physicist at WPE
    “Having witnessed the early beginnings when RayStation only supported CT import and IMPT-optimization, I must say that the current functionalities of RayStation are tremendous. Now we routinely use Monte Carlo dose calculation, deformable image registration and robust optimization as standard planning technique. More than 80 patients benefit daily from the treatment plans performed in RayStation at our clinic, and over 250 pediatric cases are being treated at WPE, the largest pediatric radiation oncology center in Europe. The manifold research projects linked to RayStation and the roadmap ahead make us believe that RaySearch will continue to improve RayStation year after year.”
    The high-quality user experience and cutting edge features of RayStation made it an obvious choice for Apollo Proton Cancer Centre.
    Dr. Preetha Reddy, Vice Chairperson, Apollo Hospitals Group
    Together through this partnership with RaySearch, we aim to bring further benefits of high-definition imaging to the oncology continuum of care.
    Toshio Takiguchi, president and CEO, Canon Medical
    We have a strong focus on comprehensive cancer care at the Princess Margaret and uniting the different clinical disciplines is a key priority. RayCare will enable us to achieve this. It will also provide us with an integrated cancer informatics platform that builds on the significant advances we have made in this area. This is a collaboration that will shape the future of oncology systems.
    Mary Gospodarowicz, medical director at Princess Margaret
    “This collaboration agreement with RaySearch is important for the global advancement of ion beam therapy. Together we will take the technology forward to improve treatment for patients worldwide.”
    Koji Noda, Director general of NIRS
    “The implementation of the RayStation Monte Carlo dose engine has expanded our capability to serve more and a wider range of patients. For example, it enabled us to use larger range shifter to patient air gaps, which streamlined our process in the treatment rooms. In addition, the higher accuracy of the Monte Carlo dose engine allowed us to treat sites like lung, complicated head and neck, and breast with more confidence.
    Chang Chang, Director of Physics, Texas Center for Proton Therapy
    RayStation® can provide treatment planning tools for all kinds of radiation therapy so an advanced clinical partner, such as First Coast Oncology, that offers multiple treatment techniques can utilize our state-of-the-art software for a broad spectrum of cancer treatments.
    Johan Löf, CEO RaySearch Laboratories AB
    RaySearch has been at the forefront of innovative treatment planning software and has now assembled all of the most technologically advanced tools for patient evaluation into one system.
    Scot Ackerman, MD, Medical Director of First Coast Oncology
    Pick a time period -
    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top